Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

drug side effects

Engagement Table

Discover who are the most engaging Pharma companies on Twitter

With engagement such a key performance metric we first created a weighted formula, incorporating likes, retweets and replies, which produced an engagement score for each account.

An agency called Owen

Pharma Social Media Ranking - Global Twitter Edition 2018 - Owen Health

Pharma Social Media Ranking – Global Twitter Edition 2018

This 2018 pharma social media ranking from healthcare agency Owen Health provides a snapshot of the performance of 22 of the largest pharma companies on Twitter.

An agency called Owen

- PMLiVE

Health coverage across state lines

Despite a total lack of legislative wins, the new administration has made its presence felt at home and abroad

Social Media and Health: the Cure or the Disease?

Social media is going through a crisis. So is this the right time for the pharma industry to join the conversation?

Life Healthcare Communications

- PMLiVE

MHRA joins Instagram as part of Yellow Card drive

UK medicines regulator follows in the footsteps of NICE in using the channel

- PMLiVE

Novartis files CAR-T therapy CTL109 in Europe

Analysts predict Kymriah could become a $1bn-plus product in Europe

EU flag

EU’s 10-year paediatric meds report – not bad, but can do better

Paper highlights the lack of ‘major therapeutic advances’ in children’s medicine

- PMLiVE

EMA sets aside £32m for temporary staff to help with Brexit move

As agency warns current tender system needs to be updated

- PMLiVE

AAA’s orphan drug Lutathera wins EU green light

The first-in-class drug treats adults with GEP-NET

Content Shock

Is your content good enough to power your multi-channel marketing?

Content shock is the time when increasing volumes of content intersect our limited human capacity to consume it.

An agency called Owen

- PMLiVE

EMA faces ‘permanent damage’ if forced to go to an unpopular city

Warns eight candidate cities wouldn't retain minimum staff numbers it needs

Roche Basel Switzerland

UK is first to receive Roche’s rare lung cancer drug

Alecensa made available under MHRA's early access scheme

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links